On Jan. 13, 2021, Mateon Therapeutics reported positive interim results from its ARTI-19 clinical trial evaluating ARTIVedaTM against COVID-19. ARTIVeda is Mateonﾒs lead Ayurvedic drug against COVID-19 in India and is being developed by Mateon in partnership with Windlas Biotech.